Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.8% | −6.3% | +0.9% | −18.9% | −0.8% | +9.4% | +57.3% | — | — | +32.3% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$55 of every $1,000 in IBRN is Biogen
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | BIIBBiogen | Healthcare | 5.52% | $552.41 | 1,826 | $451K |
| 2 | NBIXNeurocrine Biosciences | Healthcare | 4.94% | $494.18 | 2,578 | $404K |
| 3 | ALKSAlkermes | Healthcare | 4.90% | $490.47 | 8,676 | $401K |
| 4 | EWTXEdgewise Therapeutics | Healthcare | 4.68% | $468.40 | 9,294 | $383K |
| 5 | AXGNAxogen | Healthcare | 4.57% | $456.79 | 6,622 | $373K |
| 6 | SRRKScholar Rock | Healthcare | 4.47% | $446.86 | 7,247 | $365K |
| 7 | ARGXArgenx SE | Healthcare | 4.46% | $446.29 | 387 | $365K |
| 8 | PRAXPraxis Precision Medicines | Healthcare | 4.33% | $432.73 | 1,137 | $353K |
| 9 | PTCTPTC Therapeutics | Healthcare | 4.15% | $414.61 | 5,807 | $339K |
| 10 | 326030.KSSK Biopharmaceuticals | Healthcare | 3.97% | $397.28 | 4,956 | $325K |
| 11 | DNTHDianthus Therapeutics | Healthcare | 3.83% | $383.29 | 3,691 | $313K |
| 12 | HLUN-B.COH. Lundbeck | Healthcare | 3.78% | $378.00 | 34K | $309K |
| 13 | DYNDyne Therapeutics | Healthcare | 3.24% | $323.76 | 16K | $264K |
| 14 | ACADAcadia Pharmaceuticals | Healthcare | 3.09% | $308.85 | 14K | $252K |
| 15 | XENEXenon Pharmaceuticals | Healthcare | 3.09% | $308.84 | 6,717 | $252K |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | BIIB | Biogen | 5.52% |
| 2 | NBIX | Neurocrine Biosciences | 4.94% |
| 3 | ALKS | Alkermes | 4.90% |
| 4 | EWTX | Edgewise Therapeutics | 4.68% |
| 5 | AXGN | Axogen | 4.57% |
| 6 | SRRK | Scholar Rock | 4.47% |
| 7 | ARGX | Argenx SE | 4.46% |
| 8 | PRAX | Praxis Precision Medicines | 4.33% |
| 9 | PTCT | PTC Therapeutics | 4.15% |
| 10 | 326030.KS | SK Biopharmaceuticals | 3.97% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 16, 2025 | Dec 19, 2025 | $0.32 |
| Dec 17, 2024 | Dec 20, 2024 | $0.10 |
| Dec 20, 2023 | Dec 27, 2023 | $0.0063 |
| Jun 7, 2023 | Jun 13, 2023 | $0.0082 |